000			02029 a2200517 4500
005			20250513130407.0
264		0	_c19971114
008			199711s 0 0 eng d
022			_a1352-4585
024	7		_a10.1177/135245859500100210 _2doi
040			_aNLM _beng _cNLM
100	1		_aJacobs, L D
245	0	0	_aA phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients. Multiple Sclerosis Collaborative Research Group (MSCRG). _h[electronic resource]
260			_bMultiple sclerosis (Houndmills, Basingstoke, England) _cJun 1995
300			_a118-35 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAntiviral Agents _xadministration & dosage
650	0	4	_aClinical Protocols _xstandards
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aInjections, Intramuscular
650	0	4	_aInterferon-beta _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultiple Sclerosis _xdrug therapy
650	0	4	_aPatient Selection
650	0	4	_aProspective Studies
650	0	4	_aRecombinant Proteins _xadministration & dosage
650	0	4	_aResearch Design
650	0	4	_aTreatment Outcome
700	1		_aCookfair, D L
700	1		_aRudick, R A
700	1		_aHerndon, R M
700	1		_aRichert, J R
700	1		_aSalazar, A M
700	1		_aFischer, J S
700	1		_aGoodkin, D E
700	1		_aGranger, C V
700	1		_aSimon, J H
773	0		_tMultiple sclerosis (Houndmills, Basingstoke, England) _gvol. 1 _gno. 2 _gp. 118-35
856	4	0	_uhttps://doi.org/10.1177/135245859500100210 _zAvailable from publisher's website
999			_c9316436 _d9316436